🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/06/1985 0,0212 USD
28/02/1985 0,0212 USD
03/12/1984 0,0212 USD
31/08/1984 0,0199 USD
29/05/1984 0,0199 USD
01/03/1984 0,0199 USD
29/11/1983 0,0199 USD
29/08/1983 0,0186 USD
31/05/1983 0,0186 USD
28/02/1983 0,0186 USD
30/11/1982 0,0186 USD
30/08/1982 0,0186 USD
01/06/1982 0,0186 USD
01/03/1982 0,0186 USD
01/12/1981 0,0186 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/12/2020 79,98 80,04 78,76 79,65 +0,35% 1,60% 7.168.320
08/12/2020 78,52 79,90 78,49 79,37 +0,81% 1,80% 8.664.969
07/12/2020 78,30 79,65 78,29 78,73 +0,70% 1,73% 8.829.190
04/12/2020 77,42 78,21 77,40 78,19 +0,60% 1,05% 8.651.554
03/12/2020 78,19 78,22 77,12 77,72 -0,46% 1,40% 7.085.109
02/12/2020 78,19 78,95 77,57 78,08 +0,34% 1,77% 7.165.805
01/12/2020 77,24 78,68 77,12 77,81 +1,44% 2,03% 10.166.543
30/11/2020 76,34 76,85 75,77 76,71 +0,66% 1,41% 14.501.910
27/11/2020 76,62 76,98 75,92 76,20 -0,25% 1,39% 5.644.528
25/11/2020 76,47 76,77 75,95 76,39 -0,10% 1,07% 6.023.590
24/11/2020 76,36 77,19 76,02 76,47 -0,17% 1,52% 12.790.840
23/11/2020 76,92 77,44 75,74 76,60 -0,21% 2,21% 9.498.548
20/11/2020 76,78 77,11 76,08 76,77 +0,07% 1,34% 8.415.440
19/11/2020 77,07 77,07 75,70 76,71 +0,17% 1,78% 7.037.110
18/11/2020 77,70 78,22 76,56 76,57 -1,53% 2,14% 8.678.174
17/11/2020 77,35 78,21 76,73 77,77 +1,65% 1,91% 9.509.133
16/11/2020 77,51 78,14 76,05 76,51 -1,12% 2,70% 9.503.474
13/11/2020 76,56 78,10 76,07 77,38 +1,54% 2,65% 7.694.206
12/11/2020 76,86 77,29 75,41 76,20 -1,48% 2,45% 7.464.799
11/11/2020 78,12 78,12 76,90 77,35 -0,06% 1,56% 5.741.678
10/11/2020 78,03 78,27 77,30 77,40 +0,76% 1,25% 8.593.914
09/11/2020 80,90 81,27 76,67 76,81 +0,17% 5,69% 11.184.046
06/11/2020 75,81 77,42 75,81 76,68 -0,12% 2,13% 6.945.515
05/11/2020 78,30 79,10 76,76 76,77 -0,20% 3,00% 9.277.210
04/11/2020 76,28 79,09 75,90 76,93 +4,81% 4,19% 14.731.422
03/11/2020 73,92 74,65 73,24 73,40 +0,27% 1,90% 7.693.578
02/11/2020 72,95 73,34 72,18 73,20 +1,99% 1,60% 8.145.475
30/10/2020 71,93 72,41 70,55 71,77 -0,90% 2,59% 11.096.748
29/10/2020 72,68 73,08 71,25 72,41 -0,38% 2,52% 9.314.310
28/10/2020 73,60 74,17 72,54 72,69 -2,32% 2,22% 8.989.954